These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25539433)

  • 1. Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection.
    Simoes J; Sciascia S; Camara I; Baldovino S; Karim Y; Roccatello D; Cuadrado MJ
    J Clin Rheumatol; 2015 Jan; 21(1):35-7. PubMed ID: 25539433
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic response to intravenous high dose gamma-globulin in refractory vasculitis of the skin associated with Sjögren's syndrome.
    Durez P; Tourné L; Feremans W; Mascart-Lemone F; Heenen M; Appelboom T
    J Rheumatol; 1998 May; 25(5):1032-3. PubMed ID: 9598925
    [No Abstract]   [Full Text] [Related]  

  • 3. High-dose pooled immunoglobulin in the therapy of systemic vasculitis.
    Jayne DR; Lockwood CM
    Trans Assoc Am Physicians; 1991; 104():304-12. PubMed ID: 1845155
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hypogammagammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation.
    Ankersmit HJ; Hacker S; Hoetzenecker K; Moser B; Wolner E
    J Heart Lung Transplant; 2006 Nov; 25(11):1387-8. PubMed ID: 17097508
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preliminary results of intravenous immunoglobulins in treating patients with vasculitis].
    Antonelli A; Agostini G; Agostini S
    Clin Ter; 1992 Sep; 141(9 Pt 2):33-6. PubMed ID: 1468195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dramatic responses to intravenous immunoglobulin in vasculitis.
    Boman S; Ballen JL; Seggev JS
    J Intern Med; 1995 Oct; 238(4):375-7. PubMed ID: 7595175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intravenous immune globulin in multiple myeloma.
    Chapel HM; Lee M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):21-4. PubMed ID: 8033429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients.
    Kreuter A; Gambichler T; Breuckmann F; Bechara FG; Rotterdam S; Stücker M; Altmeyer P
    J Am Acad Dermatol; 2004 Oct; 51(4):574-9. PubMed ID: 15389193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis.
    Palsson R; Choi HK; Niles JL
    J Rheumatol; 2002 Mar; 29(3):505-10. PubMed ID: 11908563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment.
    Odum J; D'Costa D; Freeth M; Taylor D; Smith N; MacWhannell A
    Nephrol Dial Transplant; 2001 Feb; 16(2):403-6. PubMed ID: 11158422
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of intravenous immunoglobulins in bacterial infections].
    Beloborodova NV; Popov DA
    Anesteziol Reanimatol; 2006; (6):72-6. PubMed ID: 17288272
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin.
    Lear S; Eren E; Findlow J; Borrow R; Webster D; Jolles S
    J Clin Pathol; 2006 Nov; 59(11):1191-3. PubMed ID: 17071803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case of acute deep neck infection in a patient with aplastic anemia].
    Hiraki N; Fujiyoshi T; Udaka T; Shiomori T; Tokui N; Yoshida M; Makishima K
    Nihon Jibiinkoka Gakkai Kaiho; 2002 May; 105(5):577-80. PubMed ID: 12061092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical therapy of infections in neutropenic patients.
    Gaya H
    Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.
    Femia AN; Eastham AB; Lam C; Merola JF; Qureshi AA; Vleugels RA
    J Am Acad Dermatol; 2013 Oct; 69(4):654-7. PubMed ID: 24034377
    [No Abstract]   [Full Text] [Related]  

  • 19. Human intravenous immunoglobulin and its traceability.
    Nolan D; O'Connor MB; Lynch D; Breen K
    Ir Med J; 2009 May; 102(5):160-1. PubMed ID: 19623817
    [No Abstract]   [Full Text] [Related]  

  • 20. 5th International symposium on IVIG: IVIG in the third millenium, 25-27 September 2003, Interlaken, Switzerland.
    Shoenfeld Y
    Autoimmun Rev; 2004 Mar; 3(3):234-41. PubMed ID: 15110237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.